Robert Malcolm to Clinical Trials as Topic
This is a "connection" page, showing publications Robert Malcolm has written about Clinical Trials as Topic.
Connection Strength
0.562
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.230
-
A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study. Subst Abuse Treat Prev Policy. 2008 Jun 03; 3:13.
Score: 0.223
-
New anticonvulsants: a review of applications for the management of substance abuse disorders. Ann Clin Psychiatry. 2002 Dec; 14(4):233-45.
Score: 0.038
-
Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
Score: 0.021
-
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21.
Score: 0.015
-
Silver acetate gum as a deterrent to smoking. Chest. 1986 Jul; 90(1):107-11.
Score: 0.012
-
A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
Score: 0.011
-
Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res. 2004 Feb; 28(2):233-46.
Score: 0.010
-
Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr. 1986; 67:66-72.
Score: 0.003